These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24916933)

  • 1. The use of prn medication in a child and adolescent mental health inpatient service in France.
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Int J Psychiatry Clin Pract; 2009; 13(4):253-8. PubMed ID: 24916933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of pro re nata medications in acute inpatient care.
    Stein-Parbury J; Reid K; Smith N; Mouhanna D; Lamont F
    Aust N Z J Psychiatry; 2008 Apr; 42(4):283-92. PubMed ID: 18330770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro re nata medication for psychoses: an audit of practice in two metropolitan hospitals.
    Geffen J; Sorensen L; Stokes J; Cameron A; Roberts MS; Geffen L
    Aust N Z J Psychiatry; 2002 Oct; 36(5):649-56. PubMed ID: 12225449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing utilization of pro re nata ('as needed') sedation in a child and adolescent psychiatric inpatient unit.
    Dean AJ; Scott J; McDermott BM
    Aust N Z J Psychiatry; 2009 Apr; 43(4):360-5. PubMed ID: 19296292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotropic medication use in the child and adolescent psychiatry wards of a French hospital.
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Pharm World Sci; 2008 Oct; 30(5):600-4. PubMed ID: 18493863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive analysis of pro re nata medication use at a Canadian psychiatric hospital.
    Martin K; Arora V; Fischler I; Tremblay R
    Int J Ment Health Nurs; 2017 Aug; 26(4):402-408. PubMed ID: 27804222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of a good practice manual on professional practice associated with psychotropic PRN in acute mental health wards: an exploratory study.
    Baker JA; Lovell K; Harris N
    Int J Nurs Stud; 2008 Oct; 45(10):1403-10. PubMed ID: 18313059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pro re nata medication for psychiatric inpatients: time to act.
    Hilton MF; Whiteford HA
    Aust N Z J Psychiatry; 2008 Jul; 42(7):555-64. PubMed ID: 18612858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychotropic PRN use among older people's inpatient mental health services.
    Baker JA; Keady J; Hardman P; Kay J; Jones L; Jolley D
    J Psychiatr Ment Health Nurs; 2010 Jun; 17(5):463-8. PubMed ID: 20584243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic drug prescription in a psychiatric university hospital.
    Voirol P; Robert PA; Meister P; Oros L; Baumann P
    Pharmacopsychiatry; 1999 Jan; 32(1):29-37. PubMed ID: 10071180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRN medication for psychiatric inpatients.
    Craven JL; Voore PM; Voineskos G
    Can J Psychiatry; 1987 Apr; 32(3):199-203. PubMed ID: 2882833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administered antipsychotic pro re nata medications in psychiatric inpatients. Pre- and post-accreditation comparison.
    Al-Sughayir MA
    Saudi Med J; 2014 Feb; 35(2):172-7. PubMed ID: 24562517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
    Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
    Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro re nata medication for psychoses: the knowledge and beliefs of doctors and nurses.
    Geffen J; Cameron A; Sorensen L; Stokes J; Roberts MS; Geffen L
    Aust N Z J Psychiatry; 2002 Oct; 36(5):642-8. PubMed ID: 12225448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Psychotropic PRN Medications in a Canadian Psychiatric Intensive Care Unit.
    Casol M; Tong A; Ng JCY; McGloin R
    J Am Psychiatr Nurses Assoc; 2023; 29(2):103-111. PubMed ID: 34109871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro re nata use in a psychiatric intensive care unit.
    Mullen A; Drinkwater V
    Int J Ment Health Nurs; 2011 Dec; 20(6):409-17. PubMed ID: 21564456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of prn and stat medication in three child psychiatric inpatient settings.
    Kaplan SL; Busner J
    Psychopharmacol Bull; 1997; 33(1):161-4. PubMed ID: 9133769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project.
    Kyou Y; Yasui-Furukori N; Hasegawa N; Ide K; Ichihashi K; Hashimoto N; Hori H; Shimizu Y; Imamura Y; Muraoka H; Iida H; Ohi K; Yasuda Y; Ogasawara K; Numata S; Iga JI; Tsuboi T; Ochi S; Kodaka F; Furihata R; Onitsuka T; Makinodan M; Komatsu H; Takeshima M; Kubota C; Hishimoto A; Atake K; Yamagata H; Kido M; Nagasawa T; Usami M; Kishimoto T; Kikuchi S; Matsumoto J; Miura K; Yamada H; Watanabe K; Inada K; Hahimoto R
    Ann Gen Psychiatry; 2022 Dec; 21(1):52. PubMed ID: 36567327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Psychotropic
    Kyou Y; Oishi S; Takizawa T; Yoshimura Y; Hashimoto I; Suzuki R; Demizu R; Ono T; Noguchi Y; Kimura T; Inada K; Miyaoka H
    Clin Psychopharmacol Neurosci; 2023 May; 21(2):332-339. PubMed ID: 37119226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.